(Q38416924)

2 September 2017

title

Evaluating the health impact of a public-private partnership: to reduce rotavirus disease in Nicaragua (English)

1 reference

2 September 2017

0 references

Shazia Khawaja

1

1 reference

2 September 2017

Anna Cardellino

2

1 reference

2 September 2017

Diana Klotz

3

1 reference

2 September 2017

Barbara J Kuter

4

1 reference

2 September 2017

Mark B Feinberg

5

1 reference

2 September 2017

Brenda D Colatrella

6

1 reference

2 September 2017

T Christopher Mast

7

1 reference

2 September 2017

publication date

12 April 2012

1 reference

Human Vaccines & Immunotherapeutics

2 September 2017

published in

1 reference

2 September 2017

volume

8

1 reference

2 September 2017

issue

6

1 reference

2 September 2017

page(s)

777-782

1 reference

The Mectizan Donation Program: 20 years of successful collaboration - a retrospective

2 September 2017

cites work

1 reference

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program

21 January 2018

1 reference

Rotavirus vaccines: current prospects and future challenges

21 January 2018

1 reference

Outbreak of rotavirus gastroenteritis with high mortality, Nicaragua, 2005.

21 January 2018

1 reference

Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias

21 January 2018

1 reference

The effect of rotavirus vaccine on diarrhoea mortality

21 January 2018

1 reference

Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4161/HV.19757

1 reference

2 September 2017

1 reference